Aspirin Responsiveness in Women With Coronary Artery Disease
This study has been completed.
Information provided by (Responsible Party):
First received: July 13, 2011
Last updated: August 28, 2012
Last verified: August 2012
The purpose of this study is to measure the percentage of women with known Coronary Artery Disease (CAD) who are hyporesponsive to low dose (81 mg) aspirin.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Aspirin Responsiveness in Women With Coronary Artery Disease|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Creighton University:
Primary Outcome Measures:
- Women With Known CAD Who Are Hyporesponsive to Low Dose (81 mg) Aspirin [ Time Frame: Time of enrollment ] [ Designated as safety issue: No ]Hyporesponsive was defined as Aspirin Response Unit (ARU) > 550 equating to less than 50% platelet inhibition.
|Study Start Date:||June 2011|
|Study Completion Date:||April 2012|
|Primary Completion Date:||April 2012 (Final data collection date for primary outcome measure)|
Aspirin 81 mg
Women with CAD taking 81 mg aspirin.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01406990
|United States, Nebraska|
|The Cardiac Center at Creighton University|
|Omaha, Nebraska, United States, 68131|
Sponsors and Collaborators
|Principal Investigator:||Katie Packard, PharmD||Creighton University|